SZ168 treats LPS-induced acute lung injury by inhibiting the activation of NF-&#954;B and MAPKs pathways.

Heng, Junfeng; Wu, Dingye; Zhao, Yiming; Lu, Shiqi

SZ168 treats LPS-induced acute lung injury by inhibiting the activation of NF-κB and MAPKs pathways.

Heng, Junfeng; Wu, Dingye; Zhao, Yiming; Lu, Shiqi.

Afiliação

Heng J; Intensive Care Unit, Wuxi People's Hospital, Wuxi 214023, Jiangsu, China.
Wu D; Intensive Care Unit, Wuxi People's Hospital, Wuxi 214023, Jiangsu, China.
Zhao Y; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shi-Zi Road, Suzhou 215006, Jiangsu, China. Electronic address: abwidu@163.com.
Lu S; Department of Emergency, The First Affiliated Hospital of Soochow University, 188 Shi-Zi Road, Suzhou 215006, Jiangsu, China. Electronic address: lushiqi2004@126.com.

Respir Physiol Neurobiol ; 307: 103965, 2023 01.

Article em En | MEDLINE | ID: mdl-36150645

Assuntos

Lesão Pulmonar Aguda; NF-kappa B; Camundongos; Animais; NF-kappa B/metabolismo; Lipopolissacarídeos/toxicidade; Lipopolissacarídeos/metabolismo; Ocludina/metabolismo; Lesão Pulmonar Aguda/induzido quimicamente; Lesão Pulmonar Aguda/tratamento farmacológico; Pulmão; Fator de Necrose Tumoral alfa/metabolismo

Palavras-chave

Acute lung injury; Inflammatory response; MH-S cells; SZ168

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: NF-kappa B / Lesão Pulmonar Aguda Limite: Animals Idioma: En Revista: Respir Physiol Neurobiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google